Actively Recruiting

Phase Not Applicable
Age: 60Years +
All Genders
ID06004739

Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection

Led by Mount Sinai Hospital, Canada · Updated on 2024-09-19

550

Participants Needed

7

Research Sites

N/A

Total Duration

On this page

Sponsors

M

Mount Sinai Hospital, Canada

Lead Sponsor

S

Sault Area Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

Delirium is a sudden state of confusion commonly seen in older adults admitted to hospitals, and identifying its cause quickly is important but often difficult. Infection may cause delirium, and many patients have bacteria in their urine, but bacteria alone do not always indicate a true infection. This trial studies whether antibiotics help treat delirium in adults aged 60 and older who have delirium and suspected urinary infection but no clear signs of urinary tract infection. Participants will be randomly assigned to one of two groups: one group will start or continue taking antibiotics prescribed by their main doctor, with the antibiotic type and treatment length decided by the doctor. The other group will not receive antibiotics. This randomized controlled trial compares these approaches to see if antibiotics improve delirium in this population. During the study, researchers will assess delirium at day 7 or when participants leave the hospital, whichever comes first. They will also monitor other outcomes like hospital stay length, blood infections, ICU transfers, falls, use of restraints or antipsychotics, antibiotic days, and infections such as C. difficile up to 30 days. Deaths and hospital readmissions will be tracked for up to one year. The study aims to provide clearer guidance on antibiotic use for delirium with suspected infection in older adults.

CONDITIONS

Brief Title

Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection

Who Can Participate

Age: 60Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 60 or older and admitted to a hospital ward, including rehabilitation hospitals
  • Active delirium diagnosed by CAM criteria or physician's diagnosis
  • Less than 24 hours of antibiotic treatment before trial assessment
  • Presence of pyuria (white blood cells in urine) or bacteriuria (bacteria in urine culture)
Not Eligible

You will not qualify if you...

  • Fever above 37.9°C (100.2°F) in the past 48 hours
  • Symptoms of lower urinary tract infection (e.g., new pain during urination) or upper urinary symptoms (e.g., back tenderness)
  • Physician believes antibiotics are needed for reasons other than delirium or urine test results (e.g., pneumonia)
  • Indwelling urinary catheter used for more than 72 hours
  • Received a single-dose antibiotic sufficient for urinary tract infection treatment, such as Fosfomycin

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Up to 7 days

Participants are randomized to start or continue antibiotics as directed by their physician or to receive no antibiotics for treatment of bacteriuria.

Daily visits or assessments during hospital stay up to 7 days

Follow-up

Duration - Up to 365 days

Participants are monitored for outcomes including length of hospitalization, infections, readmissions, and survival up to 365 days after treatment.

Follow-up visits or contacts at 30 days and 365 days

Trial Site Locations

Total: 7 locations

1

Northwestern Memorial Hospital

Chicago, Illinois, United States, 60611

Not Yet Recruiting

2

The Ottawa Hospital Civic Campus

Ottawa, Canada

Not Yet Recruiting

3

The Ottawa Hospital General Campus

Ottawa, Canada

Not Yet Recruiting

4

Hennick Bridgepoint Hospital

Toronto, Canada

Not Yet Recruiting

5

Michael Garron Hospital

Toronto, Canada

Actively Recruiting

6

Mount Sinai Hospital

Toronto, Canada

Actively Recruiting

7

Toronto General Hospital

Toronto, Canada

Not Yet Recruiting

Loading map...

Research Team

M

Michael Fralick, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Multi-country, Two-arm, Open-label, Superiority, Randomise...

Infectious Disease

Actively Recruiting

2 locations

An International Observational Study of Adults With Acute In...

Infectious Disease

Actively Recruiting

47 locations

AnovaOS Network Powered Patient Registry

Infectious Disease

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here